Skip to content

Effects of different doses of esketamine on postoperative anxiety and depression in elderly abdominal surgery patients

Effects of different doses of esketamine on postoperative anxiety and depression in elderly abdominal surgery patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070763
Enrollment
Unknown
Registered
2023-04-23
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety and depression

Interventions

Control group (H group):Group H used sufentanil 2ug/kg, added normal saline to prepare 150ml solution, pump speed 0.5ml/h, add 2ml, lock for 15min.
Esketamine Group 1 (ES-1 Group):In the ES-1 group, esketamine 1mg/kg combined with sufentanil 2ug/kg was added, and normal saline was added to prepare 150ml solution, pump speed 0.5ml/h, add 2ml, and
Esketamine Group 2 (ES-2 Group):In the ES-2 group, esketamine 2mg/kg combined with sufentanil 2ug/kg was added, and normal saline was added to prepare 150ml solution, pump speed 0.5ml/h, add 2ml, and

Sponsors

Medical Ethics Committee of Hainan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.ASA I~II 2.Age= 65 years 3.Elderly patients undergoing elective laparoscopic surgery for colorectal cancer. 4.Be able to understand the process and methods of this research and voluntarily participate in this research

Exclusion criteria

Exclusion criteria: 1. Those who refuse to participate in this study; 2. Those with contraindications to general anesthesia or have had general anesthesia accidents in the past; 3. Known or suspected allergy or contraindications to esketamine, propofol injection, opioids, muscle relaxants; 4. Uncontrolled hypertension, hypotension and diabetes patients; 5. History of alcohol or drug dependence; 6. Abuse or long-term application of anesthetic, sedative, analgesic drugs; 7. Those with previous mental illness; 8. Patients who have participated in other studies in the past 2 months; 9. Subjects who the investigator believes have other factors that are not suitable to participate in this trial.

Design outcomes

Primary

MeasureTime frame
The incidence of anxiety and depression in the 24 hours postoperative period.;

Secondary

MeasureTime frame
Postoperative 2h, 4h, 24hVAS scores;Sedation scores at 2h, 4h, and 24h postoperatively;Additional analgesia;

Countries

China

Contacts

Public ContactRong Ding

Hainan General Hospital

25865236@qq.com+86 13637658716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026